Polycaprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo

Biomaterials

Volumn 33, Issue 12, 2012, Pages 3375-3387

  Shao, Zhenxing ^a   Zhang, Xin ^a   Pi, Yanbin ^a   Wang, Xiaokun ^c   Jia, Zhuqing ^b   Zhu, Jingxian ^a   Dai, Linghui ^a   Chen, Wenqing ^a   Yin, Ling ^c   Chen, Haifeng ^c   Zhou, Chunyan ^b   Ao, Yingfang ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

MSC homing; Peptide modified polycaprolactone electrospun mesh; Phage display; Tissue engineering (TE)

Indexed keywords

AFFINITY PEPTIDES; ARGININE-GLYCINE-ASPARTIC ACIDS; CARTILAGE DEFECTS; CELL SOURCES; ELECTROSPUNS; ENGRAFTMENT; HIGH EFFICACY; IMMUNOFLUORESCENCE STAINING; IN-VITRO; IN-VIVO; INFLAMMATORY CELLS; KNEE JOINT; MESENCHYMAL STEM CELL; MICRO-FRACTURE; MSC-HOMING; PEPTIDE SEQUENCES; PEPTIDE-MODIFIED POLYCAPROLACTONE ELECTROSPUN MESH; PHAGE DISPLAY; PHAGE DISPLAY TECHNOLOGY; POTENTIAL APPLICATIONS; REGENERATIVE MEDICINE; SURFACE MARKERS;

AMINO ACIDS; CELL CULTURE; FLOWCHARTING; HISTOLOGY; JOINTS (ANATOMY); PEPTIDES; TISSUE; TISSUE ENGINEERING;

POLYCAPROLACTONE;

ARGINYLGLYCYLASPARTIC ACID; CD34 ANTIGEN; CD44V ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; ENDOGLIN; POLYCAPROLACTONE; THY 1 ANTIGEN;

ABSORPTION; ADULT; AGED; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CARTILAGE INJURY; CELL GROWTH; CELL HOMING; CLINICAL ARTICLE; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; ELECTROSPINNING; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMPLANT; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MESENCHYMAL STEM CELL; MICROFRACTURE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RABBIT; RAT; SPECIES DIFFERENCE; STAINING; TISSUE ENGINEERING;

AGED; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CARTILAGE; CELL ADHESION; CELL PROLIFERATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MIDDLE AGED; PEPTIDE LIBRARY; PEPTIDES; POLYESTERS; RATS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

RATTUS;

EID: 84862779357     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.033     Document Type: Article

References (54)

1. Horwitz E.M., Le Blanc K., Dominici M., Mueller I., Slaper-Cortenbach I., Marini F.C., et al. Clarification of the nomenclature for MSC: the International Society for cellular therapy position statement. Cytotherapy 2005, 7(5):393-395.
2. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8(4):315-317.
3. Pittenger M.F. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284(5411):143-147.
4. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276(5309):71-74.
5. Vinatier C., Mrugala D., Jorgensen C., Guicheux J., Noel D. Cartilage engineering: a crucial combination of cells, biomaterials and biofactors. Trends Biotechnol 2009, 27(5):307-314.
6. Li W.-J., Tuli R., Huang X., Laquerriere P., Tuan R.S. Multilineage differentiation of human mesenchymal stem cells in a three-dimensional nanofibrous scaffold. Biomaterials 2005, 26(25):5158-5166.
7. Karp J.M., Leng Teo G.S. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009, 4(3):206-216.
8. Caplan Arnold I., Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011, 9(1):11-15.
9. Meyerrose T., Olson S., Pontow S., Kalomoiris S., Jung Y., Annett G., et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv Drug Deliv Rev 2010, 62(12):1167-1174.
10. Sarkar D., Spencer J.A., Phillips J.A., Zhao W., Schafer S., Spelke D.P., et al. Engineered cell homing. Blood 2011, 118(25):e184-e191.
11. Maijenburg M.W., van der Schoot C.E., Voermans C. Mesenchymal stromal cell migration: possibilities to improve cellular therapy. Stem Cells Dev 2011, 21(1):19-29.
12. Atala A., Bauer S.B., Soker S., Yoo J.J., Retik A.B. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006, 367(9518):1241-1246.
13. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372(9655):2023-2030.
14. Place E.S., Evans N.D., Stevens M.M. Complexity in biomaterials for tissue engineering. Nat Mater 2009, 8(6):457-470.
15. Baiguera S., Jungebluth P., Burns A., Mavilia C., Haag J., De Coppi P., et al. Tissue engineered human tracheas for in vivo implantation. Biomaterials 2010, 31(34):8931-8938.
16. Puppi D., Chiellini F., Piras A.M., Chiellini E. Polymeric materials for bone and cartilage repair. Prog Polym Sci 2010, 35(4):403-440.
17. Discher D.E., Mooney D.J., Zandstra P.W. Growth factors, matrices, and forces combine and control stem cells. Science 2009, 324(5935):1673-1677.
18. Chen F.-M., Wu L.-A., Zhang M., Zhang R., Sun H.-H. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives. Biomaterials 2011, 32(12):3189-3209.
19. Lee C.H., Cook J.L., Mendelson A., Moioli E.K., Yao H., Mao J.J. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet 2010, 376(9739):440-448.
20. Shen W., Chen X., Chen J., Yin Z., Heng B.C., Chen W., et al. The effect of incorporation of exogenous stromal cell-derived factor-1 alpha within a knitted silk-collagen sponge scaffold on tendon regeneration. Biomaterials 2010, 31(28):7239-7249.
21. Kim J.Y., Xin X., Moioli E.K., Chung J., Lee C.H., Chen M., et al. Regeneration of dental-pulp-like tissue by chemotaxis-induced cell homing. Tissue Eng Part A 2010, 16(10):3023-3031.
22. Si Y., Tsou C.L., Croft K., Charo I.F. CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice. J Clin Invest 2010, 120(4):1192-1203.
23. Dunehoo A.L., Anderson M., Majumdar S., Kobayashi N., Berkland C., Siahaan T.J. Cell adhesion molecules for targeted drug delivery. J Pharm Sci 2006, 95(9):1856-1872.
24. Shi C., Li Q., Zhao Y., Chen W., Chen B., Xiao Z., et al. Stem-cell-capturing collagen scaffold promotes cardiac tissue regeneration. Biomaterials 2011, 32(10):2508-2515.
25. Wrighton N.C., Balasubramanian P., Barbone F.P., Kashyap A.K., Farrell F.X., Jolliffe L.K., et al. Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nat Biotechnol 1997, 15(12):1261-1265.
26. Nicklin S.A., White S.J., Watkins S.J., Hawkins R.E., Baker A.H. Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation 2000, 102(2):231-237.
27. Kelly K.A., Bardeesy N., Anbazhagan R., Gurumurthy S., Berger J., Alencar H., et al. Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma. PLoS Med 2008, 5(4):e85.
28. Wan X.M., Chen Y.P., Xu W.R., Yang W.J., Wen L.P. Identification of nose-to-brain homing peptide through phage display. Peptides 2009, 30(2):343-350.
29. Yu D.H., Lu Q., Xie J., Fang C., Chen H.Z. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature. Biomaterials 2010, 31(8):2278-2292.
30. Pierschbacher M.D., Ruoslahti E. Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A 1984, 81(19):5985-5988.
31. Ruoslahti E., Pierschbacher M.D. Arg-Gly-Asp: a versatile cell recognition signal. Cell 1986, 44(4):517-518.
32. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 2003, 24(24):4385-4415.
33. Woodruff M.A., Hutmacher D.W. The return of a forgotten polymer-Polycaprolactone in the 21st century. Prog Polym Sci 2010, 35(10):1217-1256.
34. Luciani A., Coccoli V., Orsi S., Ambrosio L., Netti P.A. PCL microspheres based functional scaffolds by bottom-up approach with predefined microstructural properties and release profiles. Biomaterials 2008, 29(36):4800-4807.
35. Li C.Y., Yuan W., Jiang H., Li J.S., Xu F.J., Yang W.T., et al. PCL film surfaces conjugated with P(DMAEMA)/gelatin complexes for improving cell immobilization and gene transfection. Bioconjug Chem 2011, 22(9):1842-1851.
36. Yoo H.S., Kim T.G., Park T.G. Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery. Adv Drug Deliv Rev 2009, 61(12):1033-1042.
37. Pi Y., Zhang X., Shi J., Zhu J., Chen W., Zhang C., et al. Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display. Biomaterials 2011, 32(26):6324-6332.
38. Bourdon P., Fenton J.W., Maraganore J.M. Affinity labeling of lysine-149 in the anion-binding exosite of human alpha-thrombin with an N alpha-(dinitrofluorobenzyl)hirudin C-terminal peptide. Biochemistry 1990, 29(27):6379-6384.
39. Lu J., Cwik M., Kanyok T. Determination of paromomycin in human plasma and urine by reversed-phase high-performance liquid chromatography using 2,4-dinitrofluorobenzene derivatization. J Chromatogr B Biomed Sci Appl 1997, 695(2):329-335.
40. Chen S. The HPLC resolution of N-2,4-dinitrophenylated amino acids and peptides stereoisomers on naphthylethylcarbamate-beta-cyclodextrin bonded phase using the acetonitrile-based mobile phase: evidence for the chiral recognition pattern. Amino Acids 2004, 27(3-4):277-284.
41. Bhushan R., Kumar R. Analysis of multicomponent mixture and simultaneous enantioresolution of proteinogenic and non-proteinogenic amino acids by reversed-phase high-performance liquid chromatography using chiral variants of Sanger's reagent. Anal Bioanal Chem 2009, 394(6):1697-1705.
42. Crisan M., Yap S., Casteilla L., Chen C.W., Corselli M., Park T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3(3):301-313.
43. da Silva Meirelles L., Caplan A.I., Nardi N.B. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008, 26(9):2287-2299.
44. Fong E.L.S., Chan C.K., Goodman S.B. Stem cell homing in musculoskeletal injury. Biomaterials 2011, 32(2):395-409.
45. Liu Z.J., Zhuge Y., Velazquez O.C. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem 2009, 106(6):984-991.
46. Wang L., Li Y., Chen X., Chen J., Gautam S.C., Xu Y., et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002, 7(2):113-117.
47. Chapel A., Bertho J.M., Bensidhoum M., Fouillard L., Young R.G., Frick J., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003, 5(12):1028-1038.
48. Kreuz P.C., Steinwachs M.R., Erggelet C., Krause S.J., Konrad G., Uhl M., et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage 2006, 14(11):1119-1125.
49. Knutsen G., Drogset J.O., Engebretsen L., Grontvedt T., Isaksen V., Ludvigsen T.C., et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Jt Surg Am 2007, 89(10):2105-2112.
50. Saris D.B., Vanlauwe J., Victor J., Haspl M., Bohnsack M., Fortems Y., et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med 2008, 36(2):235-246.
51. Knutsen G., Engebretsen L., Ludvigsen T.C., Drogset J.O., Grontvedt T., Solheim E., et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Jt Surg Am 2004, 86-A(3):455-464.
52. Benthien J.P., Schwaninger M., Behrens P. We do not have evidence based methods for the treatment of cartilage defects in the knee. Knee Surg Sports Traumatol Arthrosc 2010, 19(4):543-552.
53. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
54. Grafahrend D., Heffels K.-H., Beer M.V., Gasteier P., Möller M., Boehm G., et al. Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation. Nat Mater 2010, 10(1):67-73.